Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,854
Closed -$22.4K 759
2025
Q2
$22.4K Sell
12,854
-3,513
-21% -$5.88K ﹤0.01% 586
2025
Q1
$39.3K Sell
16,367
-53
-0.3% -$173 ﹤0.01% 479
2024
Q4
$58.1K Sell
16,420
-19,491
-54% -$77.1K 0.01% 465
2024
Q3
$152K Sell
35,911
-1,352
-4% -$5.85K 0.02% 426
2024
Q2
$140K Sell
37,263
-3,135
-8% -$14.3K 0.01% 438
2024
Q1
$219K Sell
40,398
-3,481
-8% -$20.1K 0.03% 472
2023
Q4
$271K Sell
43,879
-2,202
-5% -$10.8K 0.05% 373
2023
Q3
$239K Hold
46,081
0.05% 349
2023
Q2
$232K Sell
46,081
-2,321
-5% -$9.41K 0.09% 222
2023
Q1
$178K Hold
48,402
0.1% 214
2022
Q4
$174K Buy
+48,402
New +$254K 0.09% 186

Other funds holding OABI

Atom Investors's OABI Position: Q3 2025 in Review

Atom Investors sold out of OmniAb (OABI) in Q3 2025, closing a stake of 12,854 shares — an estimated $22.4K sold.

Atom Investors first reported a position in OABI in Q4 2022 and held it in 11 quarters. The position peaked at $271K in Q4 2023. 140 funds tracked by Wall St. Rank hold OABI as of Q3 2025.

  • Atom Investors reported no remaining OmniAb position as of Q3 2025 after selling out during the quarter.
  • Atom Investors sold 12,854 OmniAb shares in Q3 2025, an estimated $22.4K.
  • Atom Investors first reported a position in OmniAb in Q4 2022 and held it in 11 quarters.
  • Atom Investors's OmniAb position peaked at $271K in Q4 2023.
  • 140 funds tracked by Wall St. Rank held OmniAb as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.